Gupta Madhulika, Ha Khanh, Agarwal Rupesh, Quarles Leigh Darryl, Smith Jeremy C
UT/ORNL Center for Molecular Biophysics, Oak Ridge National Lab, Oak Ridge, Tennessee, USA.
Tickle College of Engineering, University of Tennessee, Knoxville, Tennessee, USA.
Proteins. 2021 Feb;89(2):163-173. doi: 10.1002/prot.26002. Epub 2020 Sep 16.
Human interleukin-6 (hIL-6) is a multifunctional cytokine that regulates immune and inflammatory responses in addition to metabolic and regenerative processes and cancer. hIL-6 binding to the IL-6 receptor (IL-6Rα) induces homodimerization and recruitment of the glycoprotein (gp130) to form a hexameric signaling complex. Anti-IL-6 and IL-6R antibodies are clinically approved inhibitors of IL-6 signaling pathway for treating rheumatoid arthritis and Castleman's disease, respectively. There is a potential to develop novel small molecule IL-6 antagonists derived from understanding the structural basis for IL-6/IL-6Rα interactions. Here, we combine homology modeling with extensive molecular dynamics (MD) simulations to examine the association of hIL-6 with IL-6Rα. A comparison with MD of apo hIL-6 reveals that the binding of hIL-6 to IL-6Rα induces structural and dynamic rearrangements in the AB loop region of hIL-6, disrupting intraprotein contacts and increasing the flexibility of residues 48 to 58 of the AB loop. In contrast, due to the involvement of residues 59 to 78 in forming contacts with the receptor, these residues of the AB loop are observed to rigidify in the presence of the receptor. The binary complex is primarily stabilized by two pairs of salt bridges, Arg181 (hIL-6)- Glu182 (IL-6Rα) and Arg184 (hIL-6)- Glu183 (IL-6Rα) as well as hydrophobic and aromatic stacking interactions mediated essentially by Phe residues in both proteins. An interplay of electrostatic, hydrophobic, hydrogen bonding, and aromatic stacking interactions facilitates the formation of the hIL-6/IL-6Rα complex.
人白细胞介素-6(hIL-6)是一种多功能细胞因子,除了调节代谢、再生过程和癌症外,还能调节免疫和炎症反应。hIL-6与白细胞介素-6受体(IL-6Rα)结合会诱导同二聚化,并募集糖蛋白(gp130)形成六聚体信号复合物。抗IL-6和IL-6R抗体分别是临床上批准的用于治疗类风湿性关节炎和Castleman病的IL-6信号通路抑制剂。基于对IL-6/IL-6Rα相互作用结构基础的理解,有开发新型小分子IL-6拮抗剂的潜力。在此,我们将同源建模与广泛的分子动力学(MD)模拟相结合,以研究hIL-6与IL-6Rα的结合。与无配体hIL-6的MD比较表明,hIL-6与IL-6Rα的结合会诱导hIL-6的AB环区域发生结构和动力学重排,破坏蛋白内接触,并增加AB环48至58位残基的灵活性。相反,由于59至78位残基参与与受体形成接触,在受体存在的情况下,观察到AB环的这些残基会变硬。二元复合物主要由两对盐桥(Arg181(hIL-6)-Glu182(IL-6Rα)和Arg184(hIL-6)-Glu183(IL-6Rα))以及基本上由两种蛋白质中的苯丙氨酸残基介导的疏水和芳香堆积相互作用稳定。静电、疏水、氢键和芳香堆积相互作用的相互作用促进了hIL-6/IL-6Rα复合物的形成。